Table 3.
Polyphenol | Route of Administration | Aging Inductor | Research Model | Mechanism | Main Senotherapeutic Effects | Reference |
---|---|---|---|---|---|---|
Apigenin | In vitro | UVA and UVB | Human dermal fibroblasts | ↓ ROS ↓ NF-kB pathway ↓ MAPK ↓ MMP-1 |
↑ Viability ↑ Collagen synthesis ↑ DNA repair |
[148,168] |
Topical | UVA | Mice | ↓ ROS ↓ NF-kB pathway ↓ MAPK ↓ MMP-1 |
↑ Dermal thickness ↑ Collagen deposition |
[169] | |
Baicalin | In vitro | UVB | Human dermal fibroblasts, human skin samples | ↓ ROS ↓ MMP-1, MMP-3 ↓ p16, p21, p53 |
↑ Collagen synthesis ↑ Viability ↓ DNA damage ↓ Apoptosis |
[81] |
In vitro | UVC | Human keratinocytes | ↓ ROS | ↓ DNA damage | [170] | |
Ferulic acid | In vitro | UVA | Human dermal fibroblasts | ↓ ROS ↑ SOD1 ↑ CAT ↓ p16 ↓ MMP-1, -3 |
↑ Proliferation and cell cycle ↑ ECM reconstruction |
[171] |
Fisetin | In vitro | Hydrogen peroxide | Human keratinocytes | ↓ ROS ↓ NF-kB ↓ iNOS ↓ COX-2 ↓ IL-1β, -6, TNF-α |
↓ SASP secretion ↑ Viability |
[172] |
In vitro | UVB | Human dermal fibroblasts | ↓ ROS ↓ MAPK/AP-1/MMP |
↓ SASP secretion ↓ Collagen degradation |
[173] | |
Gallic acid | In vitro | UVB | Human dermal fibroblasts | ↓ ROS ↓ MMP-1 ↓ IL-6 |
↑ Procollagen type I | [174] |
Topical and oral | UVB | Mice | ↑ TGF-β1 ↓ MMP-1 ↓ IL-6 |
↓ Wrinkle formation ↓ Skin dryness ↑ Procollagen type I ↑ Elastin |
||
Genistein | Topical | UVB | Mice | ↓ ROS ↓ DNA pyrimidine dimer formation |
↓ DNA damage | [175] |
Luteolin | In vitro and topical | UVA | Human dermal fibroblasts, human keratinocytes, and human skin explants | ↓ ROS ↓ MMP-1 ↓ IL-6, -20 ↓ p38/MAPK |
↓ SASP secretion ↓ Collagen degradation ↓ Hyaluronic acid degradation |
[176] |
Naringenin | Intraperitoneal | UVB | Mice | ↓ ROS ↓ MMP-9 ↓ TNF-α, IFN-γ ↓ IL-1β, -4, -5, -6, -12, -13, -17, -22, -23 |
↓ SASP secretion ↓ Inflammatory infiltrations |
[177] |
Topical | UVB | Mice | ↓ ROS ↓ IL-1β, -6, -10, TNF-α |
↓ SASP secretion | [178] | |
Nectandrin B | In vitro | Cell passage ≥72 | Human diploid fibroblasts | ↓ ROS ↑ AMPK ↓ p16, p21, p27, p53 ↓ Cyclin D1 ↓ SA-β-gal ↓ Caveolin-1 |
↓ Senescence ↓ Apoptosis |
[179] |
Piceatannol | In vitro | UVB | Human keratinocytes | ↓ ROS ↑ GSH ↓ NF-kB ↓ MMP-1 |
↓ Melanogenesis ↑ Collagen synthesis ↓ Photoaging |
[180] |
Quercetin | In vitro | Cell passage ≥17 | Human dermal fibroblasts | ↓ ROS ↑ SOD2, -3 ↑ CAT ↓ p16, p53 |
↓ Senescence ↑ Mitochondrial membrane potential |
[181] |
AMPK: AMP-activated protein kinase; AP-1: activator protein 1; CAT: catalase; ECM: extracellular matrix; GPx: glutathione peroxidase; GSH-Px: plasma glutathione peroxidase; HO-1: heme oxygenase 1; IFN-γ: interferon gamma; IL: interleukin; MAPK: mitogen-activated protein kinase; MCP-1: monocyte chemoattractant protein-1; MDA: malondialdehyde, COX-2: cyclooxygenase 2; MMP: matrix metalloproteinase; NF-kB: nuclear factor kappa B; nHDF: normal human dermal fibroblasts; nPC12: neuronally differentiated phenchromocytoma cells; p16: cyclin-dependent kinase inhibitor 2A; p21: cyclin-dependent kinase inhibitor 1; p27: cyclin-dependent kinase inhibitor 1B; p38/MAPK: mitogen-activated protein kinase p38; ROS: reactive oxygen species; SA-β-gal: senescence-associated beta-galactosidase; SASP: senescence-associated secretory phenotype; SOD: superoxide dismutase; TGF-β1: transforming growth factor beta 1; TNF-α: tumor necrosis factor alpha; UVA: ultraviolet A; UVB: ultraviolet B; UVC: ultraviolet C; ↑: increase; ↓: decrease.